Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland · Delayed Price · Currency is PLN 71.30
-0.20 (-0.28%)
Sep 4, 2026, 5:00 PM CET
WSE:CTX Cash Flow Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -42.65 | -42 | -38.43 | -70.58 | -35.89 | -32.57 |
Depreciation & Amortization | 4.04 | 4.37 | 5.06 | 5.44 | 7.09 | 7.36 |
Other Operating Activities | -26.23 | -28.57 | 29.85 | 1.86 | 5.32 | 9.94 |
Change in Accounts Receivable | 1.42 | 36.57 | -25.88 | -3.07 | 1.53 | -9.88 |
Change in Other Net Operating Assets | -9.5 | -7.69 | -2.48 | 14.15 | -1 | -3.32 |
Operating Cash Flow | -72.98 | -37.32 | -31.88 | -52.2 | -22.95 | -28.47 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.19 | -0.21 | -0.42 | -3.01 | -0.89 | -5.11 |
Investment in Securities | 29.13 | -20.93 | 0.07 | 19.67 | -19.67 | - |
Other Investing Activities | 1.61 | 1.28 | 0.63 | 3.27 | 2.93 | - |
Investing Cash Flow | 30.56 | -19.87 | 0.27 | 19.93 | -17.63 | -5.11 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -3.98 | -4.36 | -1.64 | -5.76 | -6.96 |
Lease Payments | -4.52 | -3.98 | -4.36 | -1.64 | -5.76 | -6.75 |
Net Debt Issued (Repaid) | -4.52 | -3.98 | -4.36 | -1.64 | -5.76 | -6.96 |
Issuance of Common Stock | 32.9 | 32.9 | 0 | 40.01 | 0 | 148.24 |
Other Financing Activities | -0.24 | -0.27 | -0.49 | -1.43 | -0.58 | -0.41 |
Financing Cash Flow | 28.15 | 28.65 | -4.84 | 36.94 | -6.33 | 140.88 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -14.28 | -28.54 | -36.45 | 4.67 | -46.91 | 107.29 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -73.17 | -37.53 | -32.3 | -55.21 | -23.84 | -33.59 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -3071.66% | -805.36% | -204.12% | -418.22% | -260.32% | -842.60% |
Free Cash Flow Per Share | -13.23 | -6.80 | -6.93 | -11.88 | -5.72 | -8.14 |
Levered Free Cash Flow | -26.55 | -11.99 | -52.76 | -31.35 | -17.25 | -31.7 |
Unlevered Free Cash Flow | -26.4 | -11.82 | -52.52 | -31.19 | -17.05 | -31.45 |
Free Cash Flow After Leases | -77.69 | -41.51 | -36.66 | -56.85 | -29.6 | -40.33 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.24 | 0.27 | 0.39 | 0.32 | 0.58 | 0.41 |
Change in Working Capital | -8.08 | 28.88 | -28.36 | 11.08 | 0.53 | -13.2 |